scholarly journals A Comparison Between Unstemmed and Stemmed Constrained Condylar Knee Prostheses in Primary Total Knee Arthroplasty: A Propensity Score‐Matched Analysis

2021 ◽  
Author(s):  
En‐Ze Zhao ◽  
Wei‐Nan Zeng ◽  
Zi‐Chuan Ding ◽  
Zun‐Han Liu ◽  
Zhen‐Yu Luo ◽  
...  
Keyword(s):  
Total Knee Arthroplasty ◽  
Propensity Score ◽  
Knee Arthroplasty ◽  
Primary Total Knee Arthroplasty ◽  
Knee Prostheses ◽  
Total Knee ◽  
Primary Total Knee

Thromboembolic and bleeding complications following primary total knee arthroplasty

2021 ◽  
Vol 103-B (10) ◽  
pp. 1571-1577
Author(s):  
Astrid Blicher Schelde ◽  
Janne Petersen ◽  
Thomas Bo Jensen ◽  
Kirill Gromov ◽  
Søren Overgaard ◽  
...  
Keyword(s):  
Total Knee Arthroplasty ◽  
Propensity Score ◽  
Knee Arthroplasty ◽  
Major Bleeding ◽  
Multivariable Analysis ◽  
Primary Total Knee Arthroplasty ◽  
Bleeding Complications ◽  
All Cause Mortality ◽  
Total Knee ◽  
Primary Total Knee

Aims The aim of this study is to compare the effectiveness and safety of thromboprophylactic treatments in patients undergoing primary total knee arthroplasty (TKA). Methods Using nationwide medical registries, we identified patients with a primary TKA performed in Denmark between 1 January 2013 and 31 December 2018 who received thromboprophylactic treatment. We examined the 90-day risk of venous thromboembolism (VTE), major bleeding, and all-cause mortality following surgery. We used a Cox regression model to compute hazard ratios (HRs) with 95% confidence intervals (CIs) for each outcome, pairwise comparing treatment with dalteparin or dabigatran with rivaroxaban as the reference. The HRs were both computed using a multivariable and a propensity score matched analysis. Results We identified 27,736 primary TKA patients who received thromboprophylactic treatment (rivaroxaban (n = 18,846); dalteparin (n = 5,767); dabigatran (n = 1,443); tinzaparin (n = 1,372); and enoxaparin (n = 308)). In the adjusted multivariable analysis and compared with rivaroxaban, treatment with dalteparin (HR 0.68 (95% CI 0.49 to 0.92)) or dabigatran (HR 0.31 (95% CI 0.13 to 0.70)) was associated with a decreased risk of VTE. No statistically significant differences were observed for major bleeding or all-cause mortality. The propensity score matched analysis yielded similar results. Conclusion Treatment with dalteparin or dabigatran was associated with a decreased 90-day risk of VTE following primary TKA surgery compared with treatment with rivaroxaban. Cite this article: Bone Joint J 2021;103-B(10):1571–1577.

Continued Inpatient Care After Primary Total Knee Arthroplasty Increases 30-Day Post-Discharge Complications: A Propensity Score-Adjusted Analysis

2017 ◽  
Vol 32 (9) ◽  
pp. S113-S118 ◽  
Author(s):  
Alexander S. McLawhorn ◽  
Michael C. Fu ◽  
William W. Schairer ◽  
Peter K. Sculco ◽  
Catherine H. MacLean ◽  
...  
Keyword(s):  
Total Knee Arthroplasty ◽  
Propensity Score ◽  
Knee Arthroplasty ◽  
Inpatient Care ◽  
Primary Total Knee Arthroplasty ◽  
Post Discharge ◽  
Adjusted Analysis ◽  
Total Knee ◽  
Primary Total Knee
Sign in / Sign up

Export Citation Format

Share Document